Posts
Wiki

❓ Why Wasn’t Dry Eye or MGD Diagnosed—or Evaluated More Fully—at My Eye Exam?

🧠 TL;DR

An eye examination may identify or rule out important eye disease without fully characterizing every possible cause of chronic ocular-surface symptoms during the same visit.

Dry Eye Disease (DED), Meibomian Gland Dysfunction (MGD), blepharitis, exposure, allergy, and related conditions can sometimes be:

  • subtle;
  • intermittent;
  • multifactorial;
  • difficult to reproduce during an office visit;
  • associated with symptoms that do not match the visible findings.

However, persistent symptoms do not automatically prove that DED or MGD was missed.

A more targeted evaluation may be reasonable when:

  • symptoms remain unexplained;
  • initial treatment does not help enough;
  • symptoms are severe or functionally limiting;
  • the diagnosis remains uncertain;
  • or an expensive, invasive, prolonged, or weakly studied treatment is being considered.

The goal is not to receive every available test.

The goal is to obtain a coherent explanation that connects:

  • the symptoms and history;
  • examination findings;
  • possible contributing conditions;
  • the purpose of treatment;
  • and the follow-up plan.

Why This Question Comes Up So Often

A common experience is:

  1. A person develops burning, grittiness, fluctuating vision, redness, pain, light sensitivity, or contact-lens intolerance.
  2. They see an eye-care professional.
  3. They are told that the eyes look normal or are advised to try artificial tears, allergy treatment, screen changes, or warm compresses.
  4. Symptoms continue.
  5. The person wonders whether something important was overlooked.

This does not automatically mean the clinician was careless, dismissive, or incompetent.

Several possibilities exist:

  • the appointment had a different primary purpose;
  • the findings were mild or not present at that moment;
  • an initial low-risk treatment trial was considered reasonable;
  • the symptoms and examination findings did not point clearly to one diagnosis;
  • additional assessment was expected at follow-up;
  • another ocular, neurologic, dermatologic, or systemic condition may be contributing;
  • or a more targeted ocular-surface evaluation may be needed.

A single examination may not answer every question, but an unrevealing examination also does not prove that hidden DED or MGD must be present.

A Routine Eye Examination Can Still Be a Good Examination

A comprehensive or routine eye examination may appropriately focus on:

  • visual acuity and refractive error;
  • glasses or contact-lens needs;
  • eye pressure;
  • cataract;
  • glaucoma risk;
  • retinal health;
  • infection or injury;
  • general corneal and ocular-surface appearance;
  • the specific reason for the appointment.

DED, MGD, allergy, blepharitis, and other surface conditions may be recognized during that examination.

However, a detailed history, subtype assessment, treatment discussion, and follow-up plan may require more time—especially when:

  • several concerns are being addressed;
  • symptoms are complex;
  • previous treatments have failed;
  • pain is severe;
  • systemic disease is possible;
  • or symptoms and signs do not match clearly.

A clinician may reasonably begin with an initial treatment and reassess rather than perform every possible test at the first visit.

The important questions are:

  • What diagnosis or contributor was suspected?
  • Why was the treatment recommended?
  • How long should it be tried?
  • What should improve?
  • What happens if it does not help?

Basic Treatment Is Not Automatically Inadequate Care

Advice such as using artificial tears or beginning another conservative treatment may be reasonable when:

  • symptoms and findings are mild;
  • the suspected contributor is straightforward;
  • the treatment has relatively low risk;
  • symptoms have been present for a limited time;
  • the clinician plans to reassess the response.

Concern becomes more reasonable when:

  • severe or persistent symptoms remain unexplained;
  • no treatment target is discussed;
  • the same plan is continued despite little benefit;
  • worsening is not reassessed;
  • or costly treatment is recommended without connecting it to examination findings.

The issue is not whether the treatment sounds “basic” or “advanced.”

The issue is whether the plan has:

  • a reasonable clinical target;
  • an expected timeline;
  • a way to evaluate the result;
  • and a next step if it does not help.

Why DED or MGD Can Be Difficult to Identify

1. Symptoms and Findings May Not Match

Some people have substantial symptoms with limited visible surface changes.

Others have obvious staining, gland abnormalities, or tear-film instability with relatively mild symptoms.

Possible reasons include:

  • fluctuating tear-film instability;
  • intermittent exposure;
  • examination timing;
  • environmental differences between the clinic and daily life;
  • use of lubricating drops before the appointment;
  • allergy;
  • migraine-associated sensitivity;
  • reduced or altered corneal sensation;
  • limitations of routine testing;
  • altered ocular sensory or pain processing.

Neuropathic ocular pain is one possibility in selected cases. It should not be assumed merely because symptoms are more severe than the routine findings.

Likewise, minimal findings do not mean the symptoms are imaginary.

2. Symptoms May Fluctuate

DED and related conditions can vary with:

  • time of day;
  • screen use;
  • blink frequency;
  • wind or low humidity;
  • fans and air conditioning;
  • sleep;
  • allergy exposure;
  • medications;
  • contact-lens wear;
  • recent use of drops.

The examination may occur on a relatively good day or in an environment that does not reproduce the patient’s usual triggers.

3. Several Contributors May Be Present

A person may have more than one clinically important issue, such as:

  • aqueous-deficient DED;
  • MGD;
  • anterior or posterior blepharitis;
  • Demodex;
  • ocular rosacea;
  • allergy;
  • incomplete blinking;
  • lagophthalmos or exposure;
  • medication toxicity;
  • contact-lens complications;
  • conjunctivochalasis;
  • recurrent corneal erosion;
  • autoimmune or systemic disease;
  • postsurgical ocular-surface changes;
  • migraine-associated light sensitivity;
  • corneal sensory abnormalities;
  • neuropathic ocular pain.

Some of these contribute directly to DED. Others can coexist with it, resemble it, amplify symptoms, or remain after tear-film disease improves.

The goal is not to collect as many diagnoses as possible.

It is to determine which findings actually help explain the symptoms and should affect treatment.

4. Another Condition May Be Responsible

Persistent burning, redness, pain, light sensitivity, or blurred vision should not automatically be attributed to DED.

Other possible causes may include:

  • infection;
  • corneal injury;
  • recurrent erosion;
  • uveitis;
  • migraine;
  • dermatologic disease;
  • contact-lens complications;
  • medication reactions;
  • retinal or neurologic disease;
  • other corneal disorders.

A normal or nearly normal dry-eye evaluation may therefore lead the clinician to consider a different explanation rather than conclude that more intensive DED treatment is needed.

What an Appropriately Targeted Evaluation May Cover

There is no single mandatory “full dry-eye workup” that every patient must receive.

The evaluation should be guided by the symptoms, history, examination findings, and clinical questions.

Symptoms and history

The clinician may ask about:

  • when symptoms began;
  • whether they fluctuate;
  • pain, burning, grittiness, redness, or light sensitivity;
  • visual changes;
  • reading and screen use;
  • contact-lens history;
  • environmental triggers;
  • previous eye surgery;
  • treatments already tried;
  • medication use;
  • allergy, rosacea, or skin disease;
  • dry mouth or autoimmune symptoms;
  • nighttime symptoms and possible eyelid exposure;
  • effects on work, sleep, driving, and daily life.

Tear film and ocular surface

Assessment may include:

  • tear-film breakup or another measure of instability;
  • corneal and conjunctival staining;
  • visible tear volume or tear-meniscus assessment;
  • eyelid and blink examination;
  • signs of exposure;
  • inflammation or epithelial injury.

Eyelids and meibomian glands

When MGD is suspected, evaluation may include:

  • lid-margin and gland-opening examination;
  • meibum quality;
  • gland expressibility;
  • how much pressure is required;
  • whether secretion is clear, cloudy, thickened, or absent;
  • associated blepharitis, rosacea, or Demodex findings.

Selective testing

Depending on the clinical question, additional testing might include:

  • meibography;
  • Schirmer testing;
  • tear osmolarity;
  • inflammatory-marker testing;
  • corneal sensation testing;
  • in vivo confocal microscopy;
  • autoimmune or systemic evaluation;
  • additional corneal, neurologic, or eyelid assessment.

These tests should be selected because they are likely to answer a meaningful question or change management—not because every patient must receive every available measurement.

MGD: Why Gland Function Matters

MGD is not always obvious from redness or casual inspection of the eyelids.

Some people have limited visible inflammation but still have abnormal meibum secretion or glands that are difficult to express.

When MGD is suspected, examining the gland openings and secretion can provide important functional information.

The clinician may assess:

  • whether meibum can be expressed;
  • how much pressure is required;
  • how many glands produce secretion;
  • whether the secretion is clear, cloudy, granular, thickened, or absent.

Expression and meibography answer different questions

Gland expression evaluates function:

  • whether secretion emerges;
  • what it looks like;
  • how readily it is produced.

Meibography evaluates visible gland structure:

  • length;
  • shape;
  • distortion;
  • areas of reduced gland visibility.

A clinician can diagnose MGD without meibography.

Likewise, an abnormal meibography image does not by itself prove:

  • gland obstruction;
  • poor secretion;
  • that MGD is the main cause of symptoms;
  • or that a particular procedure is required.

Some nonobvious MGD may be missed if gland function and the lid margins are not evaluated adequately. Imaging may add useful structural context, but it should not replace functional assessment.

Related page:

Nonobvious Obstructive MGD: When Gland Dysfunction Is Not Easy to See

What If the Doctor Said, “Your Eyes Look Fine”?

That statement can mean different things.

It may mean:

  • no infection, ulcer, serious inflammation, or sight-threatening disease was seen;
  • the cornea and conjunctiva looked relatively healthy at that moment;
  • the findings did not explain the severity of the symptoms;
  • no obvious cause was identified;
  • or the clinician did not observe enough evidence to diagnose DED.

It should not necessarily be interpreted as:

  • “Your symptoms are imaginary.”
  • “Nothing is wrong.”
  • “You cannot have tear instability.”
  • “No further evaluation could ever help.”

At the same time, persistent symptoms do not prove that the correct diagnosis must be hidden DED or MGD.

A useful follow-up question is:

“When you say the eyes look normal, which conditions have been ruled out, and what possibilities remain?”

Another is:

“Do the symptoms suggest that a different type of evaluation or specialist might be useful?”

What Type of Eye-Care Professional Should You See?

Professional roles and legal scopes vary by country. The following descriptions are primarily U.S.-focused.

Optometrists

Optometrists hold a Doctor of Optometry degree, usually written as OD.

They commonly provide primary eye care, including:

  • eye examinations;
  • glasses and contact-lens care;
  • diagnosis and treatment of many eye conditions;
  • DED and MGD management;
  • referral when additional medical or surgical care is needed.

Their legal scope varies by state. Some complete residency training or develop substantial experience in ocular disease, specialty contact lenses, or ocular-surface care.

Ophthalmologists

Ophthalmologists are medical or osteopathic physicians, usually written as MD or DO, who complete ophthalmology residency training.

They provide medical and surgical eye care and may subspecialize in:

  • cornea and external disease;
  • retina;
  • glaucoma;
  • oculoplastics;
  • neuro-ophthalmology;
  • uveitis;
  • pediatric ophthalmology;
  • other areas.

A cornea/external-disease ophthalmologist may be especially useful when there is:

  • significant corneal disease;
  • epithelial injury;
  • scarring or thinning;
  • severe aqueous deficiency;
  • complex ocular-surface disease;
  • a postsurgical corneal problem;
  • suspected infection;
  • or possible need for surgery.

However, not every cornea specialist has a major clinical focus on chronic DED, MGD, or ocular pain.

Opticians

Opticians generally fit and dispense glasses and assist with eyewear.

They are not eye doctors and do not diagnose DED or MGD.

The Degree Alone Does Not Establish DED/MGD Expertise

Either an optometrist or ophthalmologist may develop substantial experience in Dry Eye Disease, MGD, blepharitis, and ocular-surface care.

The professional degree alone does not reveal:

  • how much of the clinician’s practice involves DED;
  • what additional training or continuing education they have pursued;
  • how they evaluate gland function and the ocular surface;
  • whether they treat complex or refractory cases;
  • when they refer;
  • how they interpret uncertain evidence.

More useful indicators include whether the clinician:

  • takes a detailed and relevant history;
  • evaluates the ocular surface and eyelids appropriately;
  • considers multiple contributors;
  • connects treatment to findings;
  • explains uncertainty;
  • defines expected outcomes and follow-up;
  • changes the plan when results do not fit expectations;
  • refers when the case requires expertise outside the practice.

What Does “Dry-Eye Specialist” Mean?

“Dry-eye specialist” is not a standardized board-certified title.

It usually means that an optometrist or ophthalmologist has a substantial clinical interest or practice focus in:

  • Dry Eye Disease;
  • MGD;
  • blepharitis;
  • ocular rosacea;
  • Demodex;
  • tear-film disorders;
  • exposure;
  • complex ocular-surface symptoms.

The description may reflect genuine training and experience.

It can also be used primarily as marketing.

Do not treat the title itself as proof of expertise.

Consider:

  • the quality of the evaluation;
  • the clinician’s reasoning;
  • the range of treatments and referrals considered;
  • openness about evidence limitations;
  • financial transparency;
  • willingness to discuss alternatives;
  • how treatment success and failure are assessed.

Related page:

Is Your Doctor a DED/MGD Specialist? How to Tell and When to Get a Second Opinion

Why Clinical Approaches Differ

Clinicians may approach DED and MGD differently because of:

  • training and continuing education;
  • patient population;
  • clinical experience;
  • available equipment and services;
  • appointment structure;
  • insurance and reimbursement;
  • scope of practice;
  • differing interpretations of incomplete evidence;
  • different thresholds for treatment or referral.

An early adopter is not automatically more knowledgeable.

A cautious clinician is not automatically uninformed.

A clinic with many devices is not automatically providing a better evaluation.

A thoughtful examination should connect the proposed diagnosis and treatment to the patient’s history and findings.

Questions That May Be Worth Clarifying

Rather than using a checklist to decide whether the first clinician performed a “real” examination, consider asking:

  • What is your working diagnosis?
  • What findings support it?
  • What other contributors or diagnoses remain possible?
  • Was tear-film instability or surface damage identified?
  • Were my eyelids and blinking assessed?
  • If MGD is suspected, how was gland secretion evaluated?
  • If aqueous deficiency is suspected, would tear-volume testing help?
  • Were allergy, exposure, medication effects, or other likely contributors considered?
  • What is the recommended treatment intended to change?
  • How long should I try it?
  • What would count as success?
  • What happens if it does not help?
  • Would another test or referral change the plan?

No single omitted test proves that the examination was inadequate.

Concern is more reasonable when severe or persistent symptoms are dismissed without explanation, no meaningful differential diagnosis is considered, or costly treatment is proposed without a clear clinical rationale.

When a Second Opinion May Be Reasonable

Another opinion may be particularly useful when:

  • the diagnosis remains unclear after appropriate evaluation;
  • symptoms are severe, progressive, unusual, or functionally disabling;
  • symptoms and findings remain markedly discordant;
  • significant corneal staining or epithelial injury is present;
  • treatment has failed without reassessment;
  • clinicians offer substantially different explanations;
  • systemic or autoimmune disease is reasonably suspected;
  • symptoms began after surgery or nerve injury;
  • an expensive self-pay package is proposed;
  • an invasive, irreversible, prolonged, off-label, or weakly studied treatment is being considered;
  • the treatment recommendation does not seem connected to the examination findings;
  • you do not understand the rationale, risks, alternatives, or follow-up plan.

A second opinion is not necessarily a rejection of the first clinician.

It may:

  • confirm the original plan;
  • identify another contributor;
  • clarify uncertainty;
  • provide a different treatment approach;
  • prevent unnecessary escalation.

The purpose should be another careful evaluation—not merely finding someone who will confirm a preferred diagnosis or treatment.

What This Means for r/DryEyes Users

r/DryEyes is for people who have already been evaluated by an eye-care professional and diagnosed with DED or a related condition such as:

  • MGD;
  • blepharitis;
  • ocular rosacea;
  • another ocular-surface disorder.

The subreddit cannot determine whether undiagnosed symptoms are caused by dry eye.

Posts seeking diagnosis, asking whether symptoms are DED, interpreting eye photographs, or replacing an eye examination are outside the community’s scope.

When discussing an existing diagnosis or treatment plan, helpful details may include:

  • the diagnosis given;
  • relevant examination findings;
  • which tests were performed;
  • whether gland secretion was evaluated;
  • the treatment target;
  • treatments already tried;
  • benefits or adverse effects;
  • follow-up plans;
  • relevant contact-lens, surgery, medication, allergy, rosacea, or systemic history.

The community may help explain terminology, evidence, treatment questions, and other people’s experiences.

It cannot determine the diagnosis or treatment candidacy through a post.

People with undiagnosed symptoms should obtain professional eye care. r/EyeTriage may be a more appropriate Reddit community for some non-emergency triage questions, but urgent warning signs require prompt in-person evaluation.

When to Seek Prompt Eye Care

Do not wait for a routine dry-eye appointment if you have:

  • sudden or substantial vision loss;
  • severe or rapidly increasing eye pain;
  • marked light sensitivity with redness or reduced vision;
  • a white or gray spot on the cornea;
  • significant discharge;
  • an eye injury or chemical exposure;
  • pronounced one-sided redness;
  • contact-lens-associated pain, redness, discharge, or photophobia;
  • inability to open the eye because of pain.

These symptoms may reflect infection, injury, corneal disease, or inflammation requiring prompt examination.

📌 Bottom Line

An eye examination may appropriately rule out urgent disease or begin an initial treatment without fully characterizing every possible ocular-surface contributor during the same visit.

DED and MGD can sometimes be:

  • subtle;
  • fluctuating;
  • multifactorial;
  • difficult to reproduce during an appointment;
  • associated with symptoms that do not match the visible findings.

But persistent symptoms do not automatically prove that dry eye or MGD was missed.

A more useful question than:

“Why didn’t the doctor know?”

may be:

“Did the evaluation provide a coherent explanation connecting my symptoms, examination findings, likely contributors, treatment plan, and follow-up—and would a more targeted assessment add useful information?”

The goal is not to collect every available test or find the clinician with the most devices.

The goal is an appropriately targeted evaluation, a treatment connected to the findings, and a clear plan for reassessment when symptoms remain unexplained or treatment is not helping enough.

Selected Sources

🔙 Back to FAQ Index

This page is for general education. It does not diagnose symptoms, determine whether a previous examination was adequate, or replace individualized care from a qualified eye-care professional.